BioSpace News Archive

Tandem Diabetes Care, Inc., a leading insulin delivery and diabetes technology company, announced the appointments of Rick Carpenter as Chief Technical Officer, Libba Sapitsky as Senior Vice President, Customer Care, and Rizwan Pervez as Senior Vice President, Quality and Regulatory.

Talis Biomedical Corporation, a company dedicated to advancing health equity and outcomes through the delivery of accurate infectious disease testing in the moment of need, at the point of care, announced that the Company’s Board of Directors has granted an inducement award to Brian Blaser, the Company’s newly appointed Chief Executive Officer.

At the earliest stages of a new human life, cells that seem identical begin to divide into distinct types that eventually grow into a diverse array of tissues and organs.

InnoCare Pharma, a commercial-stage biotech company, announced that its BTK inhibitor orelabrutinib has been included in the updated National Reimbursement Drug List by the China National Healthcare Security Administration.

Skin aesthetic devices are used in various applications including facial & body contouring, congenital defect repair, and reconstructive surgeries.

Point-of-care testing for glucose monitoring is a valuable tool for managing patients with diabetes in the outpatient settings. Coupling of POCT glucose monitoring devices and electronic medical records enable test results to be shared instantly with care providers.

Biofrontera Inc. (Nasdaq: BFRI), a biopharmaceutical company specializing in the commercialization of dermatological products, announced today that the United States Patent and Trademark Office (USPTO) has issued a Notice of Allowance for the U.S. patent application number 17/234,490, titled “Illumination for Photodynamic Therapy,” that covers an innovative, pain-reducing illumination protocol for photodynamic therapy (PDT).

LivaNova PLC (NASDAQ:LIVN), a market-leading medical technology and innovation company, today announced its participation in the American Epilepsy Society (AES) Annual Meeting taking place December 3 – 7 in Chicago, Illinois.

Petros Pharmaceuticals, Inc. (Nasdaq: PTPI), a leading provider of therapeutics for men’s health, announces today that President and Chief Commercial Officer Fady Boctor will present at the Benzinga Global Small Cap Conference.

AbCellera (Nasdaq: ABCL), a technology company with a centralized operating system for next-generation antibody discovery, announced today the appointment of Neil Aubuchon as Chief Commercial Officer (CCO).